Showing results (1501-1510 of 3,660) with videos related to

Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|May 21, 2022
Understanding the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trialsWanyuan Cui, Kelly-Anne Phillips, Prudence A Francis, et al.
Breast (Edinburgh, Scotland)|June 4, 2021
The role of CDK4/6 inhibitors in early breast cancerMiguel Gil-Gil, Emilio Alba, Joaquín Gavilá, et al.
Breast (Edinburgh, Scotland)|June 26, 2021
Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-studyAriane Mamguem Kamga, Oumar Billa, Sylvain Ladoire, et al.
Breast (Edinburgh, Scotland)|June 11, 2021
Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in MexicoCynthia Villarreal-Garza, Fernanda Mesa-Chavez, Ana S Ferrigno, et al.
Breast (Edinburgh, Scotland)|April 5, 2020
Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer - A randomized controlled trialMaria Fjell, Ann Langius-Eklöf, Marie Nilsson, et al.
Breast (Edinburgh, Scotland)|January 25, 2020
Improving breast cancer care coordination and symptom management by using AI driven predictive toolkitsE C Moser, Gayatri Narayan
Breast (Edinburgh, Scotland)|January 26, 2020
Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup - the "ATRESS" phenomenonPatriek Jurrius, Thomas Green, Hans Garmo, et al.
Breast (Edinburgh, Scotland)|March 23, 2020
Dual HER2 blockade in the first-line treatment of metastatic breast cancer - A retrospective population-based observational study in Danish patientsThomas Christensen, Tobias Berg, Lise Birk Nielsen, et al.
Breast (Edinburgh, Scotland)|March 16, 2020
Evaluation of the 8th edition of the American joint committee on cancer's pathological staging system in prognosis assessment and treatment decision making for stage T1-2N1 breast cancer after mastectomySan-Gang Wu, Jun Wang, Chen-Lu Lian, et al.
Breast (Edinburgh, Scotland)|December 3, 2019
Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2-14)Frédérique Penault-Llorca, Fabrice Kwiatkowski, Antoine Arnaud, et al.
Pageof 366